"I love BICO - The Bio Convergence Company - We create the future of health"

2022-05-17 02:45:14

INVESTORSENGLISHEnglishSvenska Who we areAbout BICOWhy invest in BICO?What is Bio Convergence?CareerWork at BICOOpen positionsBICO voicesMeet the PeopleBICO PodcastWhat we doBusiness areasOverviewBiosciencesBioautomationBioprintingCompaniesProductsOverviewspheroONEBIO X6 3D BioprinterBIO CELLXC.WASHFocus areasResearchEventsSustainabilityInitiativesEnding Animal TestingNewsPress ReleasesBICO in the pressBICO news feed Contact us Who we areAbout BICOWhy invest in BICO?What is Bio Convergence?CareerWork at BICOOpen positionsBICO voicesMeet the PeopleBICO PodcastWhat we doBusiness areasOverviewBiosciencesBioautomationBioprintingCompaniesProductsOverviewspheroONEBIO X6 3D BioprinterBIO CELLXC.WASHFocus areasResearchEventsSustainabilityInitiativesEnding Animal TestingNewsPress ReleasesBICO in the pressBICO news feed InvestorsLanguageEnglishSvenska Contact us The Future of Life-saving TreatmentsWe reduce the world's organ shortage and speed up drug development by providing life science solutions that combine biology and technology.Who we areBICO Acquires Allegro 3DLearn moreEnabling physiologically relevant models for drug discovery3D Bioprinting Set To Propel Medical Research Forward← Latest NewsMass-Produced Stem Cells: A Gateway to Personalized MedicineCuring Cardiac Diseases with 3D Printed Heart TissueView All Customer Stories →Printing the Future of HealthOur revolutionary bioprinting workflows are enabling the future of health through bioprinting of tissues and organs. Together with our new automation software from Biosero, we will enhance the user experience and speed up research and development around the world.Learn more →Play VideoSee How it WorksBico by numbers Net sales FY 2021 0 MUSD Organic growth FY 2021 0 % Employees 0 + Instruments in the field 0 + Publications 0 + Countries 0 + press releases 05/12/22BICO Group adds senior IR manager to its executive management05/11/22Invitation to presentation of BICO’s Q1 results 202205/06/22BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology – complementing the existing offering of application tailored products05/02/22RegulatoryBusiness update for BICO Group AB (publ)04/29/22New Interim CFO at BICO04/27/22BICO's Board of Directors: "Full confidence in the CEO, management and current strategic direction"04/26/22RegulatoryBulletin from Annual General Meeting in BICO Group AB (publ)04/26/22RegulatoryBICO's CFO Gusten Danielsson leaves his assignment04/20/22The BICO Group has been awarded 7 iF design awards for excellence in product design03/31/22BICO Companies win Red Dot Design Award for Outstanding Product Design03/25/22MatTek Announces Production and Shipping of EpiOral Tissues from European Facility to Better Service the Wider Market03/24/22RegulatoryNotice to Attend the Annual General Meeting in BICO Group AB (Publ)03/23/22MatTek Enters Distribution Agreement and Strategic Partnership with Cell4Pharma03/16/22RegulatoryBICO publishes Annual Report 202103/09/22Nanoscribe introduces Extra Large Feature Print Set to extend 3D Microfabrication capabilities to print centimetre-sized structures03/03/22Cellenion Announces Opening of BICO’s First Single Cell Analysis Centre of Excellence03/02/22SCIENION Announces Study Results for PoC-BoSens, an Optofluidic-based Infectious Disease Diagnostic Platform03/01/22CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture02/28/22RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes02/23/22BICO has reached a beneficial and sustainable solution with Organovo02/23/22RegulatoryYear-end report 2021: Strong growth, positive EBITDA, and a clear plan for increased profitability02/22/22Biosero Expands Laboratory Automation Capabilities with New Product Launches02/17/22MatTek’s Lab-Grown Human Tissues Head to Space.02/16/22CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies.02/16/22Invitation to earnings call for Year-end report 202102/03/22Biosero Joins Genedata Ready-to-Run Program to Streamline Lab Automation and Data Analysis02/02/22DISPENDIX to Introduce Two Disruptive Liquid Handling Platforms at SLAS 202201/31/22RegulatoryBICO Group AB (publ) announces an increase in number of shares and votes01/25/22Nanoscribe Launches Quantum X align, a high-precision 3D Printer Enabling Auto-Aligned Printing on Optical Fibers and Photonic Chips01/19/22SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform01/13/22BICO Partners with the Center for Contemporary Sciences to Reduce Animal Testing in Life Sciences01/11/22Statement from BICO regarding counterclaims in patent lawsuit by Organovo against group company CELLINK12/28/21BICO completes the acquisition of Biosero12/20/21BICO moves to Nasdaq Stockholm’s Large Cap Segment12/16/21BICO invites to a teleconference about the acquisition of Biosero12/16/21RegulatoryBICO has entered into an agreement to acquire Biosero, a leading software provider for automated workflows and laboratory connectivity12/15/21CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter12/14/21BICO Endorses FDA Modernization Act of 202112/10/21BICO’s CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model12/09/21BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant12/08/21BICO wins SwedenBIO Award 202112/07/21BICO’s CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies11/25/21BICO ranked top-three fastest-growing technology company in Sweden by Deloitte11/24/21CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing11/17/21BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors11/17/21RegulatoryBulletin from the extraordinary general meeting in BICO Group AB (publ)11/16/21Cellenion Announces Co-Marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-Based Proteomics Analysis11/15/21Cellenion Announces Co-Marketing Agreement for Single Cell Mass Spectrometry-Based Proteomics Analysis11/15/21BICO’s group companies CELLINK and CYTENA win five German Design Awards for Excellent Product Design11/10/21RegulatoryInterim report January-September 2021: Continued strong organic growth, improved gross margin and supply chain challenges Read more Products We’re equipping hundreds of labs with technologies that fuel groundbreaking scientific breakthroughs. Explore a selection of products within BICO.Learn more ➝Industry Leaders Shaping the Future of Health With Our ProductsBICO News FeedDiscover the latest news from our business areas. May 16, 2022Bico BICO joins The North American 3Rs Collaborative’s (NA3RsC) Microphysiological Systems (MPS) Initiative May 12, 2022Bico BICO Group adds senior IR manager to its executive management May 11, 2022Dispendix SLAS Europe 2022 – Dublin May 6, 2022Cellenion cellenONE Training & Workshop – June 2022 Read more FINANCIAL REPORTS03/16/22Annual report 202102/23/22Year-end report January-December 202111/10/21Interim report January-September (Q3) 202108/18/21Interim report January-June (Q2) 2021Calendar 05/18/22Interim report January-March 2022 08/24/22Interim report January-June 2022 11/09/22Interim report January-September 2022 02/22/23Year-end report 2022 BICO in the press 02/18/22 Technology Networks3D Bioprinting Set To Propel Medical Research Forward12/28/21 3DPrint.com2022 Predictions: Bioprinting Leaders Weigh in12/20/21 ForbesOp-Ed: The FDA Modernization Act Can Leverage Technology To Accelerate Drug Discovery And Save Millions Of Animals12/17/21 Genetic Engineering & Biotechnology NewsBICO Group Expands into Software with Up-to-$165M Biosero Acquisition12/16/21 San Diego Union TribuneSan Diego’s Biosero acquired by Swedish life sciences tech firm for $165 million12/16/21 3D Printing Media NetworkBICO Endorses FDA Modernization Act of 202112/15/21 3D Printing IndustryCELLINK And Nanoscribe Announce New Jointly-Developed Quantum X Bio 3D Printer12/14/21 3DPrint.comBICO Announces Million-Dollar Contract for 3D Printed Joint Implants12/07/21 Drug Discovery & DevelopmentCYTENA Inks $10M Deal to Distribute its Single-Cell Isolators in China11/26/21 Nordic Life Science NewsThese are the 5 nominees for the SwedenBIO Award11/18/21 PharmTechFocusBICO Announces Appointment of Susan Tousi as New Member of the Board of Directors11/16/21 GenomeWebBruker, Cellenion Ink Comarketing Agreement for Single-Cell Proteomics11/15/21 GenomeWebThermo Fisher Scientific, Cellenion Partner to Develop Workflows for Single-Cell Proteomics Analysis11/10/21 GenomeWebCellenion Expands Automated Cell Sorting Market, Targets Spheroids10/22/21 Life Science SwedenBICO Awarded the Export Success of the Year10/19/21 Mass DeviceBICO’s Cytena launches C.Station automated cell line development platform for antibody and gene therapies10/14/21 3D Printing Media NetworkBICO grows IP portfolio with patents in the United States and Sweden10/07/21 BioSpaceBICO Group Acquires QInstruments09/28/21 360DxScienion, Pictor Developing High-Throughput SARS-CoV-2 Antibody Testing System09/22/21 3D Printing Media NetworkCELLINK, MatTek and Visikol launch 3D Bioprinting CRO09/20/21 3DPrint.comNanoscribe’s New Microfabrication 3D Printer Makes Complex Structures for Life Sciences09/17/21 3D Printing IndustryNanoscribe Launches the Quantum X Shape 3D Printer09/01/21 Genetic Engineering & Biotechnology NewsBuying Spree: Rebranded BICO Bets Big on “Bioconvergence”08/31/21 San Diego Business JournalAdvanced BioMatrix Acquired by BICO for $15M08/27/21 AIThorityBICO has Acquired Advanced BioMatrix, an Innovative Company focused on 3D Applications08/26/21 GenomeWebScienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab08/20/21 Nordic Life Science NewsCELLINK rebrands itself to BICO08/19/21 3D Printing IndustryCELLINK Parent Firm Rebranded BICO, Reports Over 600% Acquisition-Led Growth in H1 202108/18/21 Boston Business JournalBioprinting startup restructures on the verge of 'bioconvergence revolution' Read more We are BICOWe extend the boundaries of what’s possible to give people better and healthier lives.Read more about usWe are BICOWe extend the boundaries of what’s possible to give people better and healthier lives.Read more about us Subscribe and stay updated with the latest news! Subscribe Contact [email protected] BICOCompaniesNewsInvestorInvestor websiteFinancial reportsFinancial calendarPoliciesSupplier code of conductInternal code of conductWhistleblower/speak up channelPrivacy PolicyCookie policyInstagramTwitterLinkedin Copyright © 2022 BICO - The Bio Convergence Company - All rights reserved. Contact us!This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.